Selected Abstracts

A Study of Long Noncoding RNAs Expression Levels in the CSF of Multiple Sclerosis Patients

Anna Iacoangeli, Natalie Favret, Clara Arndtsen, and Saud A. Sadiq, MD Presented at the American Academy of Neurology (AAN) 2019 Annual Meeting, held May 4-7, 2019 in Philadelphia, Pennsylvania.

Cerebrospinal Fluid of Primary Progressive MS Patients Impairs Remyelination in an Experimental Model of Multiple Sclerosis

Anna Roselle, Serena Shimshak, Jamie Wong, Saud A. Sadiq, MD Presented at the American Academy of Neurology (AAN) 2019 Annual Meeting, held May 4-7, 2019 in Philadelphia, Pennsylvania.

Intrathecal Delivery of ALS Cerebrospinal Fluid Induces Motor Deficits and Motor Neuron Death in Mice

Jamie Wong, Anna Roselle, Serena Shimshak, and Saud A. Sadiq, MD Presented at the American Academy of Neurology (AAN) 2019 Annual Meeting, held May 4-7, 2019 in Philadelphia, Pennsylvania

Cerebrospinal Fluid Derived from Primary Progressive MS Delays Remyelination after Lysolecithin-induced Demyelination

Nathan Kung, Serena Shimshak, Jamie Wong, and Saud A. Sadiq, MD Presented at the American Academy of Neurology (AAN) 2018 Annual Meeting, held April 21-27, 2018 in Los Angeles, CA.

Cerebrospinal Fluid IgA Levels Correlate with Disease Activity in Patients with Multiple Sclerosis; A Novel Finding

Alexandra Tse, Antara Finney-Stable, Jerry Lin, and Saud A. Sadiq, MD Presented at the American Academy of Neurology (AAN) 2018 Annual Meeting, held April 21-27, 2018 in Los Angeles, CA.

Cerebrospinal Fluid S-Adenosyl Methionine Levels are Decreased in Multiple Sclerosis Patients

Matthew Mendelsohn, Brian Lyudmer, Fozia Mir, and Saud A. Sadiq, MD Presented at the American Academy of Neurology (AAN) 2018 Annual Meeting, held April 21-27, 2018 in Los Angeles, CA.

Effects of MS Donor-Derived Mesenchymal Stem Cell-Neural Progenitors (MSC-NP) on Microglial Polarization

Gillian Carling, Shayna Zanker, Saud A. Sadiq, MD, and Violaine K. Harris Presented at the American Academy of Neurology (AAN) 2018 Annual Meeting, held April 21-27, 2018 in Los Angeles, CA.

Phase I Clinical Trial Demonstrates Safety and Efficacy of Repeated Intrathecal Mesenchymal Stem Cell-Derived Neural Progenitors in Progressive Multiple Sclerosis

Violaine K. Harris, James Stark, MD, Tamara Vyshkina, Gloria Joo, Valentina Stefanova, and Saud A. Sadiq, MD Presented at the International Society for Stem Cell Research's (ISSCR) 2017 Annual Meeting, held June 14-17, 2017 in Boston, Massachusetts.

Bioactivity and Micro RNA Profile of Mesenchymal Stem Cell Neural Progenitor-Derived Extracellular Vesicles

Shayna Zanker, John Tuddenham, Tamara Vyshkina, Violaine K. Harris, and Saud A. Sadiq, MD Presented at the International Society for Stem Cell Research's (ISSCR) 2017 Annual Meeting, held June 14-17, 2017 in Boston, Massachusetts.

Increased methionine sulfoxide levels in the CSF of multiple sclerosis patients

Zerina Balic, Fozia Mir, and Saud A. Sadiq, MD Presented at the American Academy of Neurology (AAN) 2017 Annual Meeting, held April 22-28, 2017 in Boston, Massachusetts

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.